Aortic Valve Replacement for Moderate Aortic Stenosis With Left Ventricular Decompensation Early Feasibility Study
NCT ID: NCT07060183
Last Updated: 2025-07-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2027-01-31
2029-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
J-Valve TF Early Feasibility Study
NCT06034028
Clinical Outcome of Patients With Low-gradient Severe Aortic Stenosis
NCT02010177
Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis
NCT02628899
Real World Data Collection on the INSPIRIS RESILIA Aortic Valve
NCT07120048
Medtronic CoreValve REDO Study
NCT01051310
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Aortic Valve Replacement
Ross procedure
aortic valve replacement
Control
No intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ross procedure
aortic valve replacement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Max aortic velocity less than 4.0 m/sec.
* Mean aortic gradient less than 40.0 mmHg.
* 1.0 cm2 \< Aortic Valve Area \< 1.5 cm2.
* Left ventricular decompensation
Exclusion Criteria
* Documented history of cardiac amyloidosis.
55 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dermed Diagnostics, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arthur P DeMarzo
Role: STUDY_DIRECTOR
Dermed Diagnostics, Inc.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Moderate Aortic Stenosis AVR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.